Nektar Therapeutics (NKTR) 17.75 $NKTR Can Cerner (CERN)

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 12:08 PM

Nektar Therapeutics (NKTR) 17.75 $NKTR

Can Cerner (CERN) Spring a Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:45PM CDT
Cerner Corporation (CERN) is expected to report second-quarter 2016 results on Aug 2.
ANIP: 60.01 (-0.59), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46), CERN: 62.57 (+0.18)

Cardinal Health (CAH) Q4 Earnings: Disappointment in Store?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:01PM CDT
Cardinal Health Inc. (CAH) is set to report fourth-quarter fiscal 2016 earnings results on Aug 2.
ANIP: 60.01 (-0.59), CAH: 83.29 (-0.31), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46)

UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:15AM CDT
UCB (UCBJF) reported results for the first half of 2016.
BIIB: 305.29 (+15.36), AMGN: 174.32 (+2.29), NKTR: 17.75 (+0.46)

Agenus (AGEN) Posts Narrower than Expected Loss in Q2
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:47AM CDT
Agenus (AGEN) reported first-quarter 2016 loss of 24 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents.
AGEN: 5.65 (+0.10), ANIP: 60.01 (-0.59), MRK: 58.87 (+0.21), NKTR: 17.75 (+0.46)

ARIAD's (ARIA) Stock Up on Q2 Earnings & Revenue Beat
Arpita Dutt - Zacks Investment Research - Fri Jul 29, 8:23AM CDT
ARIAD (ARIA) swung to earnings in the second quarter while Iclusig sales continued to grow.
ZTS: 50.58 (+0.11), INCY: 90.66 (+0.45), ARIA: 9.69 (+0.18), NKTR: 17.75 (+0.46)

AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:16AM CDT
AstraZeneca (AZN) reported second-quarter 2016 core earnings of 83 cents per American Depositary Share, beating the Zacks Consensus Estimate of 42 cents.
INVA: 12.94 (+0.07), ANIP: 60.01 (-0.59), AZN: 33.94 (-0.20), NKTR: 17.75 (+0.46)

Becton, Dickinson (BDX) Q3 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:01AM CDT
Becton, Dickinson and Company (BDX) is set to report third-quarter fiscal 2016 earnings results on Aug 4.
BDX: 177.22 (+1.22), ANIP: 60.01 (-0.59), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46)

Nektar Therapeutics (NKTR) Worth a Look: Stock Gains 6.1%
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:45AM CDT
Nektar Therapeutics (NKTR) was a big mover last session, as the company saw its shares rise over 6% on the day.
AKAO: 3.93 (unch), NKTR: 17.75 (+0.46)

Can Ecolab (ECL) Spring an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:10PM CDT
Ecolab Inc. (ECL) is slated to announce second-quarter 2016 earnings results on Aug 2, 2016.
ZTS: 50.58 (+0.11), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46), ECL: 118.60 (+0.22)

Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:33AM CDT
Alexion's (ALXN) second-quarter 2016 earnings of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents.
INVA: 12.94 (+0.07), ANIP: 60.01 (-0.59), ALXN: 133.28 (+4.68), NKTR: 17.75 (+0.46)

Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:57AM CDT
Weight management service provider Weight Watchers International Inc. is scheduled to release second-quarter 2016 results on Aug 4.
ZTS: 50.58 (+0.11), CYTR: 0.60 (-0.05), WTW: 11.53 (-0.40), NKTR: 17.75 (+0.46)

Nektar to Announce Financial Results for the Second Quarter 2016 on Wednesday, August 3, 2016, After Close of U.S.-Based Financial Markets
PR Newswire - Wed Jul 27, 4:15PM CDT
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).
NKTR: 17.75 (+0.46)

Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:07AM CDT
Gilead Sciences' (GILD) second-quarter 2016 earnings beat the Zacks Consensus Estimate by a penny while revenues missed estimates; product sales outlook is lowered.
INVA: 12.94 (+0.07), FCSC: 1.03 (-0.06), GILD: 80.91 (+1.44), NKTR: 17.75 (+0.46)

HCA Holdings (HCA) Q2 Earnings: Uncertainty in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 5:24PM CDT
HCA Holdings Inc. (HCA) is set to report second-quarter 2016 results on Jul 28.
ZTS: 50.58 (+0.11), HCA: 76.06 (-1.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Merck KGaA's Multiple Sclerosis Drug under Review in EU
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 8:23AM CDT
Merck MGaA (MKGAF) announced that the EMA has accepted to review its MAA for cladribine tablets for the treatment of relapsing-remitting MS.
INVA: 12.94 (+0.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Evoke (EVOK) Stock Down on Poor Phase III EVK-001 Data
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 8:08AM CDT
Evoke (EVOK) announced unfavorable top-line data from a phase III study on EVK-001 for the treatment of female patients with symptomatic diabetic gastroparesis.
EVOK: 2.72 (+0.10), INVA: 12.94 (+0.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Pre-market Equity Watch on Biotechnology -- Infinity Pharma, Nektar Therapeutics, Aralez Pharma, and BIND Therapeutics
PR Newswire - Thu Jun 23, 7:20AM CDT
On Wednesday, June 22, 2016, the NASDAQ Composite ended the trading session at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% lower to finish at 17,780.83; and the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Nektar Therapeutics (NASDAQ: NKTR), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), and BIND Therapeutics Inc. (NASDAQ: BIND). Learn more about these stocks by accessing their free trade alerts at:
BIND: 0.78 (-0.09), ARLZ: 3.95 (+0.45), INFI: 1.66 (-0.02), NKTR: 17.75 (+0.46)

Preclinical Data Presented at ASCO 2016 Annual Meeting Demonstrate that Single-Agent NKTR-214 Produces a Large Increase in Tumor-Infiltrating Lymphocytes to Provide Durable Anti-Tumor Activity
PR Newswire - Mon Jun 06, 1:00PM CDT
Nektar Therapeutics (NASDAQ: NKTR) today announced new preclinical data for NKTR-214, an immuno-stimulatory CD-122 biased cytokine currently being evaluated in cancer patients with solid tumors in a Phase 1/2 clinical trial being conducted at MD Anderson Cancer Center and Yale Cancer Center. The new preclinical data presented demonstrate that treatment with single-agent NKTR-214 mobilizes tumor-killing T cells into colon cancer tumors. In addition, mouse pharmacodynamics data demonstrated that a single dose of NKTR-214 can increase and sustain STAT5 phosphorylation (a marker of IL-2 pathway activation) through one week post-dose. These data were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 3-7, 2016.
NKTR: 17.75 (+0.46)

Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2016 Global Healthcare Conference in New York City
PR Newswire - Thu Jun 02, 5:30PM CDT
Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming Jefferies 2016 Global Healthcare Conference in New York City on Wednesday, June 8, 2016 at 11:30 a.m. Eastern time.
NKTR: 17.75 (+0.46)

Nektar Therapeutics Announces Executive Management Promotions
PR Newswire - Thu Jun 02, 3:30PM CDT
Nektar Therapeutics (NASDAQ: NKTR) announced today that John Nicholson has been named Senior Vice President & Chief Operating Officer and Gil M. Labrucherie has been named Senior Vice President & Chief Financial Officer of Nektar. Mr. Nicholson has served as the Chief Financial Officer of Nektar since 2007. Mr. Labrucherie has served as Senior Vice President, General Counsel and Secretary of Nektar since 2007.
NKTR: 17.75 (+0.46)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Varda Space's Dual Launch Signals Orbital Ambitions

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Mitsubishi's Q3 Sales: SUVs Up, Mirage Out

You ever notice how the market treats innovation and tradition like they’re these ever-spinning plates in a circus act? Take Mitsubishi Motors North America (MMNA). Their third-quarter report's got me both nodding in approval and scratching my head. Sure, they sold 18,543 vehicles—down 5.6% from the previous year. But don’t write 'em off just yet. The slumping...

Sports Research Joins Costco: Creatine Mix Available

Breaking Into the Big League: Sports Research Hits Costco When a company's product finds its way onto Costco's shelves, you know they're not just playing in the minor leagues anymore. This October, Sports Research® made a bold move into the retail giant's sports nutrition section with their new Creatine + Electrolytes powder. It's not their first rodeo when it comes to...

Texas A&M-San Antonio's Research Expansion Momentum

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Managed Connectivity: Key to Modern Multifamily Living

Connectivity Runs the Modern Show Imagine moving into a shiny new apartment, where the biggest hassle isn't unpacking boxes but ensuring your gadgets get online smoothly. That's the reality of today's multifamily living, where the internet is more than a utility—it's the backbone of modern life. And if you think it's just about offering internet access, you're missing...

Li-Fire Expands Fire Safety Amid Rising Battery Risks

A Crunchy Look at New Fire Safety Moves Well, folks, here's a twist we didn't see coming but sure makes sense in today's electrifying business landscape. Li-Fire, the big brains behind lithium battery fire suppression, is spreading its wings nationwide, or at least its wholesale and distribution programs are. And right ahead of National Fire Safety Week no less—talk...

Fiber Giants Unite to Boost Connectivity in Montana

Montana's Broadband Transformation Takes a Leap Folks in Northwest Montana, take note. Vero Fiber and MontanaSky have tied the knot, officially sealing a merger that doesn't just unite two reputable broadband providers but promises to shake up the internet game across the region. Just ask anyone who's tried to stream a movie during peak hours in Flathead Valley. A...

Cannatrol and Veterans Nonprofit Unite for Healing

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Nelson-Jameson Boosts Cold Storage in California Move

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

SaponiQ Reinvents Body Care with Botanical Soap Bars

Breaking Through with Simple Innovation I'll be the first to say it's not every day you hear about a soap company trying to shake things up in body care like it’s a tech startup, but here’s SaponiQ taking a wild swing at it with their lineup of botanical cleansing bars. These things are whipped up in their own U.S.-based facility using some fancy cold-process...